Literature DB >> 18206850

Melanoma adrenal metastasis: natural history and surgical management.

Elizabeth A Mittendorf1, Sherry J Lim, Chris W Schacherer, Anthony Lucci, Janice N Cormier, Paul F Mansfield, Jeffrey E Gershenwald, Merrick I Ross, Jeffrey E Lee.   

Abstract

BACKGROUND: Few data exist regarding melanoma metastasis to the adrenal gland. We reviewed our experience to determine the natural history of this condition and the appropriate role for surgical intervention.
METHODS: A retrospective review of melanoma patients with adrenal metastasis was performed. Clinical presentation, surgical treatment, and survival were determined.
RESULTS: One hundred fifty-four patients with adrenal metastasis were identified. The median survival for the entire group was 6.4 months and was negatively impacted by the presence of synchronous metastasis or an elevated LDH. Twenty-two patients underwent surgery including 20 patients rendered disease free, either by adrenalectomy alone (14) or adrenalectomy with concomitant metastectomy (6). Patients who underwent surgery had an improved survival compared with those managed nonoperatively (P < .0001).
CONCLUSIONS: Patients with melanoma adrenal metastasis have a poor prognosis. Surgical treatment should be considered only in highly selected patients, such as those with limited extra-adrenal metastatic disease who can be rendered disease free.

Entities:  

Mesh:

Year:  2008        PMID: 18206850     DOI: 10.1016/j.amjsurg.2007.12.018

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  19 in total

1.  Addison's disease as a presentation of metastatic malignant melanoma.

Authors:  B Srinivasan; M Patel; M Ethunandan; V Ilankovan
Journal:  Ann R Coll Surg Engl       Date:  2016-01       Impact factor: 1.891

2.  Prognostic significance of adrenal gland morphology at CT in patients with three common malignancies.

Authors:  C P Meehan; J L Fuqua; A S Reiner; C S Moskowitz; L H Schwartz; D M Panicek
Journal:  Br J Radiol       Date:  2011-07-12       Impact factor: 3.039

3.  Adrenal metastectomy is safe in selected patients.

Authors:  Minerva Angelica Romero Arenas; Dawen Sui; Elizabeth G Grubbs; Jeffrey E Lee; Nancy D Perrier
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

4.  Survival Outcomes After Metastasectomy in Melanoma Patients Categorized by Response to Checkpoint Blockade.

Authors:  Danielle M Bello; Katherine S Panageas; Travis Hollmann; Alexander N Shoushtari; Parisa Momtaz; Paul B Chapman; Michael A Postow; Margaret K Callahan; Jedd D Wolchok; Mary S Brady; Daniel G Coit; Charlotte E Ariyan
Journal:  Ann Surg Oncol       Date:  2019-12-17       Impact factor: 5.344

Review 5.  Surgical management of adrenal metastases.

Authors:  Juan J Sancho; Frédéric Triponez; Xavier Montet; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2011-12-16       Impact factor: 3.445

6.  Adrenalectomy for Metastatic Melanoma: Current Role in the Age of Nonsurgical Treatments.

Authors:  Devin C Flaherty; Gary B Deutsch; Daniel D Kirchoff; Jihey Lee; Kelly T Huynh; David Y Lee; Leland J Foshag; Anton J Bilchik; Mark B Faries
Journal:  Am Surg       Date:  2015-10       Impact factor: 0.688

Review 7.  Surgery for distant melanoma metastasis.

Authors:  Anna M Leung; Danielle M Hari; Donald L Morton
Journal:  Cancer J       Date:  2012 Mar-Apr       Impact factor: 3.360

8.  The role of laparoscopic resection of metastases to adrenal glands.

Authors:  Marco Puccini; Erica Panicucci; Vincenzo Candalise; Cristina Ceccarelli; Carlo Maria Neri; Piero Buccianti; Paolo Miccoli
Journal:  Gland Surg       Date:  2017-08

Review 9.  Optimal management of metastatic melanoma: current strategies and future directions.

Authors:  Marta Batus; Salman Waheed; Carl Ruby; Lindsay Petersen; Steven D Bines; Howard L Kaufman
Journal:  Am J Clin Dermatol       Date:  2013-06       Impact factor: 7.403

10.  Landmark Series on Disparities in Surgical Oncology: Melanoma.

Authors:  Elliot A Asare; Umang Swami; John H Stewart
Journal:  Ann Surg Oncol       Date:  2021-06-30       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.